16.1
Drug Delivery Systems: Different Types
Conventional oral drug products, termed immediate-release (IR) formulations, are engineered to promptly release their active pharmaceutical ingredient…
Conventional immediate-release formulations release the active ingredient immediately upon ingestion, leading to rapid absorption. However, formulations containing poorly soluble drugs may exhibit slower absorption.
To overcome these limitations, modified-release dosage forms have been designed to control drug release patterns. Several types of modified-release oral drug products are available.
Extended-release formulations are designed to sustain drug release, maintain therapeutic levels over longer durations, and reduce dosing frequency.
Delayed-release formulations, often with enteric coatings, protect the drug from the acidic stomach environment and ensure drug release only in the intestines, optimizing absorption profiles.
Targeted-release formulations deliver drugs to specific body sites, maximizing therapeutic effects and minimizing systemic exposure. These formulations can be designed for either immediate or sustained drug release.
Orally disintegrating tablets dissolve rapidly in saliva, enabling direct buccal drug absorption and quicker therapeutic effects. They are ideal for patients who have difficulty swallowing conventional tablets.
View the full transcript and gain access to JoVE Core videos
Q1: What is the difference between immediate-release and modified-release drug formulations?
Immediate-release formulations release the active pharmaceutical ingredient promptly upon ingestion, leading to rapid absorption and quick therapeutic effects. Modified-release formulations deliberately alter drug release rate and timing to achieve specific therapeutic goals, maintain consistent drug levels, and improve patient adherence by reducing dosing frequency.
Q2: How do extended-release formulations maintain therapeutic drug levels?
Extended-release formulations utilize advanced technologies such as matrix systems and osmotic pumps to control drug release gradually over extended periods. Matrix systems embed the drug in a dissolving matrix, while osmotic pumps release drug through a semipermeable membrane opening, maintaining steady bloodstream levels and minimizing fluctuations.
Q3: Why are enteric coatings used in delayed-release formulations?
Enteric coatings protect drugs from the acidic stomach environment by resisting stomach acid and ensuring release only in the intestines. This approach optimizes absorption profiles and reduces gastric irritation, exemplified by enteric-coated aspirin, which enhances therapeutic efficacy while mitigating side effects.
Q4: What are the advantages of targeted-release drug delivery systems?
Targeted-release formulations deliver drugs directly to specific physiological sites using advanced carriers like liposomes or nanoparticles, enhancing therapeutic effects while minimizing systemic exposure. This precise delivery and localized action is particularly beneficial in treatments like cancer therapy, reducing unwanted side effects.
Q5: How do orally disintegrating tablets benefit patients with swallowing difficulties?
Orally disintegrating tablets dissolve rapidly in saliva, facilitating quick drug absorption without requiring water. This formulation enables direct buccal drug absorption and quicker therapeutic effects, making them particularly suitable for patients with swallowing difficulties or those unable to take conventional tablets.
Q6: What factors affect drug absorption in immediate-release formulations?
Drug absorption in immediate-release formulations depends on the drug's physicochemical properties. Poorly soluble drugs may exhibit slower absorption due to gradual dissolution in the gastrointestinal tract, while prodrugs require metabolic conversion to activate their effects, introducing delays in onset times.
Q7: How do modified-release formulations improve patient adherence?
Modified-release formulations reduce dosing frequency by maintaining therapeutic drug levels over extended periods, allowing patients to take medication less often. This consistent drug delivery minimizes fluctuations in blood concentration, improving treatment outcomes and making medication regimens easier for patients to follow.